Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
This study has been withdrawn prior to enrollment.
Study NCT01309685   Information provided by National Institutes of Health Clinical Center (CC)

First Received on March 4, 2011.   Last Updated on May 3, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Drug Addiction
Additional conditions recognized in this trial
Behavior, Addictive
Cognition Disorders
Substance-Related Disorders
More general conditions related to this trial
Compulsive Behavior
Delirium, Dementia, Amnestic, Cognitive Disorders
Impulsive Behavior
Mental Disorders
Interventions listed in this trial
Varenicline
More general drug interventions related to this trial
Cholinergic Agents
Cholinergic Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services